The most important non‐fluid biomarkers of state in the diagnosis of PD are dopamine transporter imaging, olfactory testing by smell tests, and rapid eye movement (REM) sleep behavior disorder (RBD) confirmed by video‐polysomnography. Here, SLC6A3 is linked to Parkinson disease.